Steven Gillis
Steven Gillis is Managing Director at ARCH Venture Partners.
University of Washington Launches Vilya with $50 Million to Develop Membrane-Permeable Peptide Drugs
University of Washington researchers developed custom peptides that penetrate cell membranes, enabling a new class of drugs with combined benefits of small molecules and protein therapeutics. They founded Vilya, backed by $50 million from Arch Venture Partners, to commercialize this drug platform described in Cell.
Fred Hutch spinout Faraday Pharmaceuticals raises $25M (up to $30M) to advance iodide drug preventing reperfusion injury and muscle loss
Faraday Pharmaceuticals, a Fred Hutch spinout, has raised $25 million (potentially up to $30 million) to develop an iodide-based drug to prevent reperfusion injury after heart attacks and ultimately limit skeletal muscle loss in stressed or bedridden patients.
Seattle’s Rodeo Therapeutics raises $4.3M more for regenerative therapies, joining prior $3.7M infusion
Rodeo Therapeutics, a Seattle regenerative medicine startup co-founded by Drs. Sanford Markowitz, Stanton Gerson, and Joseph Ready, has added $4.3 million to an earlier $3.7 million cash infusion, building on a $5.9 million Series A from 2017. The company is developing therapies for inflammatory bowel disease and treatments to accelerate cell growth after stem cell transplants, with investors including AbbVie, Lilly, Arch Venture Partners and Johnson & Johnson.
Organizations
-
ARCH Venture Partners Managing Director · current
-
Faraday Pharmaceuticals Director 2017–present · current
-
OncoResponse Director 2017–2023 · past
Online
Questions about Steven Gillis
Who is Steven Gillis?
Steven Gillis is Managing Director at ARCH Venture Partners.
Which organizations is Steven Gillis associated with?
On Seattle Flow, Steven Gillis is listed with ARCH Venture Partners, Faraday Pharmaceuticals and OncoResponse.
Where is Steven Gillis based?
Steven Gillis is based in Seattle, Washington, United States.
Where can I find Steven Gillis online?
Steven Gillis is on LinkedIn.